ASB3 E3 Ligase Targets MAVS and Suppresses Antiviral Immunit
2026-07-04
The reference study uncovers Ankyrin repeat and SOCS box-containing protein 3 (ASB3) as a novel E3 ubiquitin ligase that inhibits antiviral innate immunity by promoting K48-linked polyubiquitination and proteasomal degradation of the MAVS adaptor protein. These findings delineate an unrecognized host regulatory mechanism, illuminating new aspects of immune evasion during RNA virus infection and informing future studies on therapeutic targeting of viral pathogenesis.
Caspase-3/7 Inhibitor I: Precision Apoptosis Inhibition Work
2026-07-03
Caspase-3/7 Inhibitor I empowers researchers to dissect executioner caspase pathways with high selectivity and reversibility—crucial for mapping apoptosis in disease models. This guide delivers protocol-ready insights, comparative use-cases, and troubleshooting strategies to maximize experimental confidence.
Mitochondrial CAT-Tailing Drives Glioblastoma Growth via RQC
2026-07-03
This study elucidates how mitochondrial protein carboxyl-terminal alanine-threonine (CAT) tailing, a ribosome quality control (RQC) response, promotes glioblastoma cell survival by modulating mitochondrial function. The findings refine our understanding of metabolic regulation in cancer and highlight both mechanistic vulnerabilities and new therapeutic targets.
I-BET151 (GSK1210151A): Technical Guide for BET Inhibition W
2026-07-02
I-BET151 (GSK1210151A) is a potent, selective BET bromodomain inhibitor designed for precise modulation of BRD2, BRD3, and BRD4 in preclinical cancer biology, especially apoptosis and cell cycle arrest assays. It is not suitable for diagnostic, clinical, or water-based applications, and requires careful handling and QC for reproducible results.
SMPD4-Driven Sphingolipid Metabolism in Brain and Cilia Deve
2026-07-02
This study uncovers the essential role of SMPD4-mediated sphingolipid metabolism in brain and primary cilia development. By integrating mouse models and human iPSC systems, the research demonstrates that SMPD4-dependent ceramide production is vital for neural progenitor survival and cilia integrity, with direct implications for understanding microcephaly and cerebellar hypoplasia.
DiscoveryProbe Metabolism-related Compound Library: Experime
2026-07-01
The DiscoveryProbe Metabolism-related Compound Library enables precise, high-throughput modulation of metabolic targets with 493 rigorously validated, cell-permeable compounds. This guide delivers actionable workflow enhancements, troubleshooting tips, and translational insights—empowering metabolism research from enzyme inhibition to pathway dissection.
Small-Molecule uPAR-uPA Inhibition Suppresses Breast Cancer
2026-07-01
This study presents the development and evaluation of a small-molecule inhibitor targeting the uPAR-uPA interaction, a critical driver of breast cancer metastasis. The research combines biochemical, cellular, and in vivo approaches to demonstrate direct binding, reduced cell invasion, and suppression of metastatic spread, providing a foundation for further therapeutic development.
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer: Method
2026-06-30
This study pioneers the use of intravesical delivery of chemically modified p21 mRNA encapsulated in lipid nanoparticles (LNPs) as a targeted tumor suppressor replacement strategy for bladder cancer. By restoring p21 expression and inducing tumor suppression locally, the work offers a clinically relevant alternative to conventional therapies, with minimized systemic exposure and toxicity.
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Pract
2026-06-30
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses protein degradation during extraction and analysis, particularly in workflows where EDTA would interfere with downstream applications such as phosphorylation studies or enzyme assays. It is not suitable for protocols requiring metalloprotease inhibition by EDTA or where DMSO is incompatible with the system.
Poly(I:C): Synthetic Double-Stranded RNA Analog in Advanced
2026-06-29
Poly(I:C) is redefining experimental immune activation as a robust Toll-like receptor 3 (TLR3) agonist and dendritic cell maturation inducer. This article translates bench-proven workflows and the latest mechanistic insights into actionable steps for researchers, spotlighting how Poly(I:C) enables precision immune modeling and troubleshooting in complex inflammatory and antiviral studies.
MDL 28170, Calpain and Cathepsin B Inhibitor: Lab-Guided Sol
2026-06-29
This article presents scenario-driven guidance for biomedical researchers using MDL 28170, Calpain and Cathepsin B Inhibitor, Selective (SKU A4412), highlighting its quantitative advantages in neuroprotection, apoptosis, and cytotoxicity assays. Drawing on validated protocols and recent literature, it demonstrates how SKU A4412 consistently improves assay reliability, workflow safety, and interpretability across advanced cell and animal models.
FITC-Concanavalin A (ConA) Conjugate: Technical Usage Guide
2026-06-28
FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of cell surface α-D-glucose and α-D-mannose residues in immunofluorescence and flow cytometry workflows. It is not intended for non-carbohydrate-binding assays or for use outside its defined storage and stability parameters. Researchers should adhere to recommended handling and application practices to ensure consistent results.
Medroxyprogesterone Acetate: Decidualization, Renal, and Neu
2026-06-27
Explore how Medroxyprogesterone acetate (MPA) enables advanced modeling of steroid hormone signaling, with new insight into endometrial decidualization and renal-neurobiological pathways. This article delivers a deep scientific analysis and practical guidance beyond standard protocols.
Berberine Hydrochloride: Applied Workflows in Metabolic and
2026-06-26
Berberine Hydrochloride unlocks advanced metabolic and inflammation modeling through robust AMPK activation and inflammasome modulation. Discover how APExBIO’s formulation enables reproducible, multi-modal protocols, practical troubleshooting, and integration with the latest inflammasome research.
Targeting Pancreatic Fibrosis: MFGE8-ANXA1-SMAD2/3 Axis Insi
2026-06-26
This study demonstrates that umbilical cord-derived mesenchymal stem cells (UCMSCs) and their extracellular vesicles (EVs) attenuate pancreatic fibrosis in chronic pancreatitis by modulating the MFGE8-dependent ANXA1-SMAD2/3 signaling axis. The work further introduces rhMFGE8 nanoparticles as a promising antifibrotic strategy, providing a foundation for future cell- and nanomedicine-based therapies.
460 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page